Novocure details CEO Cordova compensation; Danziger transition terms set

NovoCure Ltd

Ashley Cordova named CEO effective Jan 1, 2025; base salary CHF 750K, target bonus 90% of base.
Cordova severance: 100% base (non-CIC) or 200% base + 200% target bonus (CIC); equity fully vests on CIC termination.
Asaf Danziger transitions to Senior Advisor through Dec 31, 2026; base salary $700K in 2025, then $120K.
Danziger receives 400,000 RSUs vesting Dec 31, 2025 and 2026; forfeits certain PSUs upon CEO resignation.
Both subject to 12-month non-compete, perpetual confidentiality, and non-disparagement covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.